Mirjam E. Van De Velde

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Extrapolating Vincristine-Induced Peripheral Neuropathy From Caucasian to Kenyan Populations: Impact of Type I and Type II Selection Bias.

Extrapolating Vincristine-Induced Peripheral Neuropathy From Caucasian to Kenyan Populations: Impact of Type I and Type II Selection Bias.

Journal: CPT: pharmacometrics & systems pharmacology

Published: March 30, 2026

Vincristine exposure in Kenyan children with cancer: CHAPATI feasibility study.

Vincristine exposure in Kenyan children with cancer: CHAPATI feasibility study.

Journal: Pediatric blood & cancer

Published: February 08, 2024

Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.

Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.

Journal: Clinical pharmacokinetics

Published: November 29, 2023

Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis).

Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis).

Journal: Cancer medicine

Published: January 18, 2023

Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745.

Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745.

Journal: Cancers

Published: September 21, 2022

Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.

Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.

Journal: Cancers

Published: May 13, 2022

A Population Pharmacokinetic Modelling Approach to Unravel the Complex Pharmacokinetics of Vincristine in Children.

A Population Pharmacokinetic Modelling Approach to Unravel the Complex Pharmacokinetics of Vincristine in Children.

Journal: Pharmaceutical research

Published: April 04, 2022

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer: A Systematic Review and Meta-Analysis.

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer: A Systematic Review and Meta-Analysis.

Journal: Cancers

Published: November 29, 2021

Carboplatin Dosing in Children Using Estimated Glomerular Filtration Rate: Equation Matters.

Carboplatin Dosing in Children Using Estimated Glomerular Filtration Rate: Equation Matters.

Journal: Cancers

Published: October 08, 2021

Outcomes of Wilms tumor treatment in western Kenya.

Outcomes of Wilms tumor treatment in western Kenya.

Journal: Pediatric blood & cancer

Published: August 13, 2021

The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer.

The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer.

Journal: Cancer medicine

Published: May 14, 2021

Prediction of Bloodstream Infection in Pediatric Acute Leukemia by Microbiota and Volatile Organic Compounds Analysis.

Prediction of Bloodstream Infection in Pediatric Acute Leukemia by Microbiota and Volatile Organic Compounds Analysis.

Journal: Journal of pediatric hematology/oncology

Published: October 25, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026